Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) investors will be delighted, with the company turning in some strong numbers with its latest results. Statutory earnings performance was extremely strong ...

As an analyst tracking small-cap biotech names, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has always been one of my favorites, thanks to the company’s evolution from a TAVALISSE-centric company ...

Rigel's partner Kissei Pharmaceutical Co., Ltd. (Kissei) announced in January that the Korean Ministry of Food and Drug Safety approved TAVALISSE for the treatment of thrombocytopenia in adult ...

Greetings, and welcome to Rigel Pharmaceuticals Financial Conference Call for the First Quarter 2025. [Operator Instructions] As a reminder, this conference is being recorded. It is now my ...

Rigel Pharmaceuticals Inc. (RIGL) reported robust financial results for Q1 2025, with total revenue reaching $53.3 million, marking a 68% year-over-year increase. The company’s net income was $ ...

Rigel Pharmaceuticals (RIGL) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might ...

Rigel Pharmaceuticals (RIGL) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to loss of $0.50 per share a year ago.

Laser-cooled atomic gases, gases of atoms chilled to temperatures around absolute zero using laser technologies, have proved to be versatile physical platforms to study and control quantum phenomena.

China has achieved a milestone feat, making the first-ever laser ranging measurement from Earth to the moon during the daytime. Researchers at Yunnan Observatories under the Chinese Academy of ...

Steve Pink‘s “Terrestrial” and Julie Pacino’s “I Live Here Now” are among the 2025 Fantasia International Film Festival’s first wave line-up, the festival announced. This year’s ...

After a failed push to compete with streaming services, SiriusXM is reshaping its strategy to directly target terrestrial radio listening. “We have a real opportunity here to take share from AM ...